Who invested in CytoPherx?
CytoPherx's investors include ONSET Ventures, Kaiser Permanente Ventures, Early Stage Partners, Aphelion Capital and Emergent Medical Partners, and 5 more on record.
United States · Venture startup
3 rounds we have observed, with the 10 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$48Mraised across 3 rounds since 2009, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $16M sold, first sale Sept 2011
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale Jun 2010
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Oct 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CytoPherx's investors include ONSET Ventures, Kaiser Permanente Ventures, Early Stage Partners, Aphelion Capital and Emergent Medical Partners, and 5 more on record.
CytoPherx has raised $48M across 3 rounds since 2009.
CytoPherx's most recent round was a Venture of $34M in Jan 2012.
Its most recent round, $34M in Jan 2012, is also its largest on record.
CytoPherx's first round on record, in Jan 2012, was backed by ONSET Ventures, Kaiser Permanente Ventures and Early Stage Partners and 7 others.
CytoPherx's latest named round is a Venture, in Jan 2012.
CytoPherx is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.